[VRTX] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
15-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 8.96%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 9,869,200 8,930,700 7,574,400 6,205,683 4,162,821 3,047,597 2,488,652 25.79%
PBT 4,379,800 4,232,400 2,730,400 3,116,798 1,394,919 600,241 -15,689 -
Tax 760,200 910,400 388,300 405,151 218,109 -1,486,862 -107,324 -
NP 3,619,600 3,322,000 2,342,100 2,711,700 1,176,810 2,096,896 263,484 54.72%
Tax Rate -17.36% -21.51% -14.22% -13.00% -15.64% 247.71% - -
Total Cost 6,249,600 5,608,700 5,232,300 3,493,983 2,986,011 950,701 2,225,168 18.77%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 36.68 37.20 30.92 43.70 28.27 68.80 10.59 22.99%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 14.05 12.97 9.09 10.44 4.58 8.25 1.06 53.80%
EPS Diluted 13.89 12.82 9.01 10.29 4.51 8.09 1.04 54.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.